Trial intelligence / Profile preview

EXERCISE: sEPCR in Cirrhosis Hypercoagulability

NCT03625726Unknown

Sponsor
Centre Hospitalier Universitaire de Clermont-Ferrand
Start
Aug 2018
Primary completion
Aug 2024
Countries
1
01

Overview

Open-label trial (3 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Thrombin generation assay (area under the curve/ Endogenous Thrombin Potential) with thrombomodulin at Day 1. Status: unknown.

Beyond the preview

Go deeper on NCT03625726.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03625726.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call